Immunocore Holdings plc (IMCR) Presentations https://www.immunocore.com/investors/events-presentations/presentations/rss en-us https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png Immunocore Holdings plc Logo /investors Equisolve Investor Relations Suite <![CDATA[Corporate Presentation - February 2026]]> https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22848/pdf/IMCR_Corporate+Deck_February_2026.pdf Mon, 27 Apr 26 07:28:01 -0400 https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22848/pdf/IMCR_Corporate+Deck_February_2026.pdf <![CDATA[IMC-M113V Phase 1 MAD Data Q1 2025]]> https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22665/pdf/IMC-M113V+Phase+1+MAD+Data+Q1+2025.pdf Mon, 27 Apr 26 07:28:01 -0400 https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22665/pdf/IMC-M113V+Phase+1+MAD+Data+Q1+2025.pdf <![CDATA[PRAME Phase 1 Cutaneous Melanoma Data – ASCO 2024]]> https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22136/pdf/2024_ASCO_Investor_Analyst+Data+Presentation_vF.pdf Mon, 27 Apr 26 07:28:01 -0400 https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/22136/pdf/2024_ASCO_Investor_Analyst+Data+Presentation_vF.pdf <![CDATA[Initial Phase 1 Data from PRAME Program (ESMO Presentation)]]> https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/21478/pdf/7b9399b0-9a13-4314-b0d1-e1e4b9065aad.pdf Mon, 27 Apr 26 07:28:01 -0400 https://d1io3yog0oux5.cloudfront.net/_193a46edfd1008a7fcf71dec2dad05c6/immunocore/db/2265/21478/pdf/7b9399b0-9a13-4314-b0d1-e1e4b9065aad.pdf